{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,5]],"date-time":"2024-07-05T08:36:32Z","timestamp":1720168592662},"reference-count":8,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","jns-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.jns.2017.08.3233","type":"journal-article","created":{"date-parts":[[2017,8,24]],"date-time":"2017-08-24T07:00:55Z","timestamp":1503558055000},"page":"341-342","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Serious assessment of mtDNA variants is a prerequisite to confirm pathogenicity"],"prefix":"10.1016","volume":"381","author":[{"given":"Josef","family":"Finsterer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sinda","family":"Zarrouk-Mahjoub","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jns.2017.08.3233_bb0005","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.jns.2017.05.056","article-title":"Mitochondrial tRNA genes are hotspots for mutations in a cohort of patients with exercise intolerance and mitochondrial myopathy","volume":"379","author":"Lu","year":"2017","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jns.2017.08.3233_bb0010","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1002\/humu.21575","article-title":"A comparative analysis approach to determining the pathogenicity of mitochondrial tRNA mutations","volume":"32","author":"Yarham","year":"2011","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.jns.2017.08.3233_bb0015","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s40291-017-0279-7","article-title":"Genetic counselling for maternally inherited mitochondrial disorders","volume":"21","author":"Poulton","year":"2017","journal-title":"Mol. Diagn. Ther."},{"key":"10.1016\/j.jns.2017.08.3233_bb0020","doi-asserted-by":"crossref","DOI":"10.1136\/archdischild-2016-311370","article-title":"Recognition, investigation and management of mitochondrial disease","author":"Davison","year":"2017","journal-title":"Arch. Dis. Child."},{"key":"10.1016\/j.jns.2017.08.3233_bb0025","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1159\/000466686","article-title":"Multisystem disease, including eosinophilia and progressive hyper-creatine-kinase-emia over 10 years, suggests mitochondrial disorder","volume":"9","author":"Finsterer","year":"2017","journal-title":"Case Rep. Neurol."},{"key":"10.1016\/j.jns.2017.08.3233_bb0030","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1007\/s00381-016-3241-9","article-title":"Cerebral involvement in mitochondrial disorders on imaging","volume":"32","author":"Finsterer","year":"2016","journal-title":"Childs Nerv. Syst."},{"key":"10.1016\/j.jns.2017.08.3233_bb0035","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1177\/1756283X16666806","article-title":"Gastrointestinal manifestations of mitochondrial disorders: a systematic review","volume":"10","author":"Finsterer","year":"2017","journal-title":"Therap. Adv. Gastroenterol."},{"key":"10.1016\/j.jns.2017.08.3233_bb0040","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.pediatrneurol.2014.06.023","article-title":"Therapeutic strategies for mitochondrial disorders","volume":"52","author":"Finsterer","year":"2015","journal-title":"Pediatr. Neurol."}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X17337292?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X17337292?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,27]],"date-time":"2018-12-27T16:42:27Z","timestamp":1545928947000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X17337292"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":8,"alternative-id":["S0022510X17337292"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2017.08.3233","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Serious assessment of mtDNA variants is a prerequisite to confirm pathogenicity","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2017.08.3233","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}